McKesson Forecasts 2027 Profit Above Analyst Estimates
McKesson expects fiscal 2027 earnings slightly above analyst targets as demand for specialty drugs remains strong. The company reported a quarterly profit beat.
Xurve View
Insights:
Xurve View
MCKESSON CORP forecast fiscal 2027 adjusted profit with a $44.20 midpoint, exceeding LSEG estimates of $44.10. The United States distributor earned $11.69 per share in the fourth quarter of fiscal 2026, beating expectations of $11.59. High-margin specialty drug demand is offsetting slower distribution trends seen at industry peers.
